These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 35493093)
1. Stratification From Heterogeneity of the Cell-Death Signal Enables Prognosis Prediction and Immune Microenvironment Characterization in Esophageal Squamous Cell Carcinoma. Zhang Y; Chen Y Front Cell Dev Biol; 2022; 10():855404. PubMed ID: 35493093 [TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y Front Oncol; 2021; 11():769727. PubMed ID: 34926275 [TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma. Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127 [TBL] [Abstract][Full Text] [Related]
4. Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma. Cao K; Zhu J; Lu M; Zhang J; Yang Y; Ling X; Zhang L; Qi C; Wei S; Zhang Y; Ma J EBioMedicine; 2024 Jan; 99():104920. PubMed ID: 38101299 [TBL] [Abstract][Full Text] [Related]
5. Identification of tumor antigens for mRNA vaccines and ferroptosis-related landscape in esophageal squamous cell carcinoma. Zeng Q; Chen B; Wang W Transl Cancer Res; 2024 Jun; 13(6):2860-2876. PubMed ID: 38988947 [TBL] [Abstract][Full Text] [Related]
6. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer. Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627 [TBL] [Abstract][Full Text] [Related]
7. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development. Lu T; Xu R; Wang CH; Zhao JY; Peng B; Wang J; Zhang LY Front Genet; 2022; 13():853113. PubMed ID: 35734437 [No Abstract] [Full Text] [Related]
8. Integrating bulk and single-cell sequencing data to construct a Scissor Cheng M; Xiong J; Liu Q; Zhang C; Li K; Wang X; Chen S Cancer Immunol Immunother; 2024 Apr; 73(6):97. PubMed ID: 38619620 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Immune-Related Multi-IncRNA Signatures Associated With Tumor Microenvironment in Esophageal Cancer. Pang J; Pan H; Yang C; Meng P; Xie W; Li J; Li Y; Xiao SY Front Genet; 2021; 12():722601. PubMed ID: 34659345 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
11. Ferroptosis patterns and tumor microenvironment infiltration characterization in esophageal squamous cell cancer. Zhang LL; Zhu WJ; Zhang XX; Feng D; Wang XC; Ding Y; Wang DX; Li YY Front Genet; 2022; 13():1047382. PubMed ID: 36568375 [No Abstract] [Full Text] [Related]
12. The identification of heterogeneous reactive oxygen subtypes in esophageal squamous cell carcinoma to aid patient prognosis and immunotherapy. Lu Q; Yang Q; Zhao J; Li G; Zhang J; Jia C; Wan Y; Chen Y Heliyon; 2024 Aug; 10(15):e35235. PubMed ID: 39165982 [TBL] [Abstract][Full Text] [Related]
13. Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy. Zheng Y; Gao Q; Su X; Xiao C; Yu B; Huang S; Sun Y; Wu S; Wo Y; Xu Q; Xu N; Yu H Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291754 [TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Ferroptosis-Related Gene Signature and Nomogram for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma. Ye J; Wu Y; Cai H; Sun L; Deng W; Liang R; Han A Front Genet; 2021; 12():697524. PubMed ID: 34764976 [TBL] [Abstract][Full Text] [Related]
15. A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma. Xu T; Dai T; Zeng P; Guo Y; He K Transl Cancer Res; 2021 May; 10(5):2354-2367. PubMed ID: 35116551 [TBL] [Abstract][Full Text] [Related]
16. Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma. Li Y; Xu F; Chen F; Chen Y; Ge D; Zhang S; Lu C EBioMedicine; 2021 Aug; 70():103510. PubMed ID: 34365093 [TBL] [Abstract][Full Text] [Related]
17. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer. Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797 [TBL] [Abstract][Full Text] [Related]
18. PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma. Chen Y; Feng R; He B; Wang J; Xian N; Huang G; Zhang Q Front Mol Biosci; 2021; 8():777370. PubMed ID: 34950702 [TBL] [Abstract][Full Text] [Related]
19. DNA damage repair profiling of esophageal squamous cell carcinoma uncovers clinically relevant molecular subtypes with distinct prognoses and therapeutic vulnerabilities. Zhao N; Zhang Z; Wang Q; Li L; Wei Z; Chen H; Zhou M; Liu Z; Su J EBioMedicine; 2023 Oct; 96():104801. PubMed ID: 37725855 [TBL] [Abstract][Full Text] [Related]
20. Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis. Zhang P; Dong S; Sun W; Zhong W; Xiong J; Gong X; Li J; Lin H; Zhuang Y Front Mol Biosci; 2023; 10():1277530. PubMed ID: 37842637 [No Abstract] [Full Text] [Related] [Next] [New Search]